首页> 外文期刊>Pharmaceutical patent analyst >Patent highlights: February-March 2016
【24h】

Patent highlights: February-March 2016

机译:专利亮点:2016年2月至3月

获取原文
获取原文并翻译 | 示例
           

摘要

In the heart, greater than 90% of angiotensin I is synthesized locally, and greater than 75% of angiotensin II is produced by enzymatic conversion of local cardiac angiotensin I [l]. Prior to the present disclosure, it was unknown how the two relevant genes are regulated in the heart. Using immunostaining, the inventors found that ACE expression in endothelial cells in the left ventricle was activated when mouse hearts were stressed by transaortic constriction, whereas expression from ACE2 was suppressed. This tilts the balance of angiotensin peptides in favor of angiotensin II, ultimately leading to cardiomyopathy. Brgl (a catalytic component of the chromatin remodeling complex) and FoxMl (the positive forkhead box transcription factor) form a protein complex with the promoters of ACE and ACE2.
机译:在心脏中,超过90%的血管紧张素I是局部合成的,而超过75%的血管紧张素II是通过局部心脏血管紧张素I的酶促转化产生的[1]。在本公开之前,未知两个相关基因如何在心脏中调节。使用免疫染色,发明人发现当小鼠心脏受到经主动脉缩窄的压力时,激活了左心室内皮细胞中的ACE表达,而抑制了来自ACE2的表达。这使血管紧张素肽的平衡偏向于血管紧张素II,最终导致心肌病。 Brgl(染色质重塑复合物的催化成分)和FoxM1(正叉头盒转录因子)与ACE和ACE2的启动子形成蛋白质复合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号